检索结果 - Jeffrey W. Tyner

Refine Results
  1. 1
    Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals

    Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals 由 Jeffrey W. Tyner

    出版 2006
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    What's different about atypical CML and chronic neutrophilic leukemia?

    What's different about atypical CML and chronic neutrophilic leukemia? 由 Kim-Hien T. Dao, Jeffrey W. Tyner

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Genomics of chronic neutrophilic leukemia

    Genomics of chronic neutrophilic leukemia 由 Julia E. Maxson, Jeffrey W. Tyner

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia

    Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia 由 Emmanuella Oyogoa, Elie Traer, Jeffrey W. Tyner, Curtis A. Lachowiez

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment

    The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment 由 Jason Gotlib, Julia E. Maxson, Tracy I. George, Jeffrey W. Tyner

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia

    Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia 由 Shovik Bandyopadhyay, Junjie Li, Elie Traer, Jeffrey W. Tyner, Amy Zhou, Stephen T. Oh, Ji‐Xin Cheng

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia

    Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia 由 Vincent T. Bicocca, Bill H. Chang, Behzad Kharabi Masouleh, Markus Müschen, Marc Loriaux, Brian J. Druker, Jeffrey W. Tyner

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Ligand Independence of the T618I Mutation in the Colony-stimulating Factor 3 Receptor (CSF3R) Protein Results from Loss of O-Linked Glycosylation and Increased Receptor Dimerization

    Ligand Independence of the T618I Mutation in the Colony-stimulating Factor 3 Receptor (CSF3R) Protein Results from Loss of O-Linked Glycosylation and Increased Receptor Dimerizatio... 由 Julia E. Maxson, Samuel B. Luty, Jason D. MacManiman, Melissa L. Abel, Brian J. Druker, Jeffrey W. Tyner

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia

    Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia 由 Kim-Hien T. Dao, Magdolna Solti, Julia E. Maxson, Elliott F. Winton, Richard D. Press, Brian J. Druker, Jeffrey W. Tyner

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations

    Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations 由 Elie Traer, Nathalie Javidi‐Sharifi, Anupriya Agarwal, Jennifer Dunlap, Isabel English, Jacqueline Martinez, Jeffrey W. Tyner, Melissa Wong, Brian J. Druker

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia

    Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia 由 Vishesh Khanna, Scott T. Pierce, Kim‐Hien T. Dao, Cristina E. Tognon, David E. Hunt, Brian Junio, Jeffrey W. Tyner, Brian J. Druker

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance

    Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance 由 Shelton A. Viola, Elie Traer, Jianya Huan, Noah I. Hornick, Jeffrey W. Tyner, Anupriya Agarwal, Marc Loriaux, Brian H. Johnstone, Peter Kurre

    出版 2015
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  13. 13
    Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma

    Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma 由 Matthew B. Siegel, Selina Qiuying Liu, Monika A. Davare, Stephen E. Spurgeon, Marc Loriaux, Brian J. Druker, Emma C. Scott, Jeffrey W. Tyner

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

    Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia 由 Haijiao Zhang, Yusuke Nakauchi, Thomas Köhnke, Melissa Stafford, Daniel Bottomly, Rozario Thomas, Beth Wilmot, Shannon K. McWeeney, Ravindra Majeti, Jeffrey W. Tyner

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

    FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia 由 Elie Traer, Jacqueline Martinez, Nathalie Javidi‐Sharifi, Anupriya Agarwal, Jennifer Dunlap, Isabel English, Tibor Kovacsovics, Jeffrey W. Tyner, Melissa H. Wong, Brian J. Druker

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia

    Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia 由 Jessica T. Leonard, Joelle Rowley, Christopher A. Eide, Elie Traer, Brandon Hayes‐Lattin, Marc Loriaux, Stephen E. Spurgeon, Brian J. Druker, Jeffrey W. Tyner, Bill H. Chang

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations

    Proteolysis targeting chimeric molecules as therapy for multiple myeloma: efficacy, biomarker and drug combinations 由 Su Lin Lim, Alisa Damnernsawad, Pavithra Shyamsunder, Wee Joo Chng, Bing Han, Liang Xu, Jian Pan, Pushkar Dakle, Serhan Alkan, Jeffrey W. Tyner, H. Phillip Koeffler

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia

    CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia 由 Animesh Pardanani, Terra L. Lasho, Rebecca R. Laborde, Michelle A. Elliott, C. Hanson, Ryan A. Knudson, Rhett P. Ketterling, Julia E. Maxson, Jeffrey W. Tyner, A Tefferi

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance

    Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance 由 Nathalie Javidi‐Sharifi, Elie Traer, Jacqueline Martinez, Anu Gupta, Takehiro Taguchi, Jennifer Dunlap, Michael C. Heinrich, Christopher L. Corless, Brian P. Rubin, Brian J. Druker, Jeffrey W. Tyner

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms

    CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms 由 Jeffrey W. Tyner, Thomas G.P. Bumm, Jutta Deininger, Lisa J. Wood, Karl J. Aichberger, Marc Loriaux, Brian J. Druker, Christopher J. Burns, Emmanuelle Fantino, Michael W. Deininger

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: